HOME › DRUGS › CAFFEINE CITRATE
ACTIVE SUBSTANCE / INN

CAFFEINE CITRATE

Brand name(s): CAFCIT, CAFFEINE CITRATE, Blectifor, Gencebok
FDA LISTED
EMA LISTED
PRESCRIPTION
APPLICATION WITHDRAWN
DISCONTINUED
Bronchopulmonary Dysplasia
ANDA091102
ACTIVE SUBSTANCE
Caffeine Citrate
REGULATORS
FDA · EMA
SPONSORS / MAH
AM REGENT, Viridian Pharma Ltd, Gennisium Pharma
TOTAL APPLICATIONS
6
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
CAFFEINE CITRATEANDA091102SAGENT PHARMSPrescription
CAFFEINE CITRATEANDA090064AM REGENTDiscontinued
CAFCITNDA020793HIKMAPrescription
CAFCITNDA020793HIKMADiscontinued
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
GencebokGennisium PharmaAuthorised19/08/2020Apnea
BlectiforViridian Pharma LtdApplication withdrawnBronchopulmonary Dysplasia

FULL INTELLIGENCE ON CAFFEINE CITRATE

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →